Capricor Therapeutics
CAPR
#7318
Rank
A$0.82 B
Marketcap
A$14.23
Share price
9.44%
Change (1 day)
66.39%
Change (1 year)

Operating Margin for Capricor Therapeutics (CAPR)

Operating Margin as of November 2026 (TTM): -181.70%

According to Capricor Therapeutics 's latest financial reports and stock price the company's current Operating Margin is -181.70%. At the end of 2021 the company had an Operating Margin of -8,175.86%.

Operating Margin history for Capricor Therapeutics from 2007 to 2022

Operating Margin at the end of each year

Year Operating Margin Change
2021-8,175.86%85.73%
2020-4,401.94%478.93%
2019-760.36%-16.34%
2018-908.91%-1096.72%
201791.19%-119.39%
2016-470.33%101.84%
2015-233.02%79.42%
2014-129.87%-92.65%
2013-1,766.96%82.48%
2012-968.31%167.71%
2011-361.70%
2007-9,369.29%
2003-739.79%377.85%
2002-154.82%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Johnson & Johnson
JNJ
34.58%-119.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
24.66%-113.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-1,321.12% 627.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-16,748.00% 9,117.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-662.26% 264.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-6,510.13% 3,482.90%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.